Invasive fungal infection after liver transplantation: Risk factors and significance of immune cell function monitoring

Journal of Digestive Diseases

Volumn 12, Issue 6, 2011, Pages 467-475

  Zhou, Tao ^a,b   Xue, Feng ^a   Han, Long Zhi ^a   Xi, Zhi Feng ^a   Li, Qi Gen ^a   Xu, Ning ^a   Zhang, Jian Jun ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ImmuKnow; Immune function assay; Invasive fungal infection; Liver transplantation; Risk factor

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; ARTICLE; BACTERIAL INFECTION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC MYCOSIS;

ADENOSINE TRIPHOSPHATE; ADULT; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS, INVASIVE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC TESTS; IMMUNOSUPPRESSION; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 82355172851     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00542.x     Document Type: Article

References (34)

1. Pappas PG, Alexander BD, Andes DR etal. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-11.
2. Husain S, Alexander BD, Munoz P etal. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221-9.
3. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-36.
4. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729-37.
5. Akamatsu N, Sugawara Y, Kaneko J, Tamura S, Makuuchi M. Preemptive treatment of fungal infection based on plasma (1-3) beta-D-glucan levels after liver transplantation. Infection 2007; 35: 346-51.
6. Razonable RR, Paya CV. Fungal infections in liver transplantation: prophylaxis, surveillance, and treatment. Curr Opin Organ Transplant 2002; 7: 137-43.
7. Rosenhagen M, Feldhues R, Schmidt J, Hoppe-Tichy T, Geiss HK. A risk profile for invasive aspergillosis in liver transplant recipients. Infection 2009; 37: 313-19.
8. Hellinger WC, Crook JE, Heckman MG etal. Surgical site infection after liver transplantation: risk factors and association with graft loss or death. Transplantation 2009; 87: 1387-93.
9. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-14.
10. Del Pozo JL. Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol 2008; 14: 4977-83.
11. Moreira AP, Cavassani KA, Massafera Tristão FS etal. CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J Immunol 2008; 180: 3049-56.
12. Chandrasekar P. Prophylaxis against Aspergillus is not perfect: problems and perils in stem cell transplantation. Med Mycol 2009; 47 (Suppl 1): S349-54.
13. Eschenauer GA, Lam SW, Carver PL. Antifungal prophylaxis in liver transplant recipients. Liver Transpl 2009; 15: 842-58.
14. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-63.
15. Reed A, Herndon JB, Ersoz N etal. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients. Liver Transpl 2007; 13: 1743-50.
16. Shi SH, Lu AW, Shen Y etal. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J (Engl) 2008; 121: 625-30.
17. Ascioglu S, Rex JH, de Pauw B etal. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
18. Kowalski R, Post D, Schneider MC etal. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77-88.
19. Xue F, Zhang JJ, Han LZ etal. Immune cell functional assay in monitoring of liver transplantation recipients with infection. Transplantation 2010; 89: 620-6.
20. Rabkin JM, Oroloff SL, Corless CL etal. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 2000; 179: 426-30.
21. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA. Causes of death in autopsied liver trasnplatation patients. Mod Pathol 1998; 11: 37-46.
22. Morgan J, Wannemuehler KA, Marr KA etal. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43 (Suppl 1): S49-58.
23. Singh N, Gayowski T, Wagener MM. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transpl 2001; 7: 100-5.
24. Sun HY, Singh N, Cacciarelli TV, Wannstedt C, Wagener MM, Steele C. Dysregulated expression of T-helper cell responses and susceptibility to infections in high-risk liver transplant recipients. Transpl Immuol 2008; 20: 68-72.
25. Serban G, Whittaker V, Fan J etal. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 2009; 70: 882-90.
26. Fishman JA, Issa NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin North Am 2010; 24: 273-83.
27. Cassone A. Fungal vaccines: real progress from real challenges. Lancet Infect Dis 2008; 8: 114-24.
28. Israeli M, Klein T, Sredni B etal. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008; 14: 893-8.
29. Israeli M, Yussim A, Mor E, Sredni B, Klein T. Preeceding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007; 18: 7-12.
30. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990-4.
31. Gautam A, Fischer SA, Yango AF, Gohh RY, Morrissey PE, Monaco AP. Cell mediated immunity (CMI) and post transplant viral infections - role of a functional immune assay to titrate immunosuppression. Int Immunopharmacol 2006; 6: 2023-6.
32. Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl 2008; 14: 1313-22.
33. Sampson VB, Dunn SP, Rymeski B etal. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg 2008; 43: 1134-41.
34. Husain S, Raza K, Pilewski JM etal. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009; 87: 1852-7.